These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM, Memish ZA, Al-Kattan KM. Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355 [Abstract] [Full Text] [Related]
4. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study. Charfi F, Smaoui H, Kechrid A. Vaccine; 2012 Dec 31; 30 Suppl 6():G18-24. PubMed ID: 23228353 [Abstract] [Full Text] [Related]
5. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon. Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G, Lebanese Inter-Hospital Pneumococcal Surveillance Program. Vaccine; 2012 Dec 31; 30 Suppl 6():G11-7. PubMed ID: 23228352 [Abstract] [Full Text] [Related]
6. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco. Diawara I, Barguigua A, Katfy K, Nayme K, Belabbes H, Timinouni M, Zerouali K, Elmdaghri N. Ann Clin Microbiol Antimicrob; 2017 Apr 04; 16(1):23. PubMed ID: 28376809 [Abstract] [Full Text] [Related]
7. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012. Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K. Hum Vaccin Immunother; 2014 Apr 04; 10(7):1866-73. PubMed ID: 25424794 [Abstract] [Full Text] [Related]
9. [Study of nasopharyngeal colonization by Streptococcus pneumoniae and its antibiotics resistance in healthy children less than 2 years of age in the Marrakech region (Morocco)]. Bouskraoui M, Soraa N, Zahlane K, Arsalane L, Doit C, Mariani P, Bingen E. Arch Pediatr; 2011 Dec 04; 18(12):1265-70. PubMed ID: 21978670 [Abstract] [Full Text] [Related]
12. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee. Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W. Pediatr Infect Dis J; 2013 Jun 04; 32(6):604-9. PubMed ID: 23348816 [Abstract] [Full Text] [Related]
13. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, Amin R, Fatima K, Brooks WA, Breiman RF, Sack DA, Luby SP, Pneumococcal Study Group. Clin Infect Dis; 2009 Mar 01; 48 Suppl 2():S75-81. PubMed ID: 19191622 [Abstract] [Full Text] [Related]
14. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH. Pediatr Infect Dis J; 2007 Jun 01; 26(6):461-7. PubMed ID: 17529859 [Abstract] [Full Text] [Related]
15. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, Active Bacterial Core Surveillance Team. J Infect Dis; 2005 Dec 01; 192(11):1988-95. PubMed ID: 16267772 [Abstract] [Full Text] [Related]
16. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. Imöhl M, Reinert RR, van der Linden M. Int J Med Microbiol; 2015 Oct 01; 305(7):776-83. PubMed ID: 26324014 [Abstract] [Full Text] [Related]